CAPTRUST Financial Advisors
TLSI icon

CAPTRUST Financial Advisors’s TriSalus Life Sciences TLSI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-24,159
Closed -$110K – 3638
2026
Q2 		$110K Buy
24,159
+2,194
+10% +$8.72K ﹤0.01% 3027
2026
Q1 		$87.9K Buy
21,965
+131
+0.6% +$641 ﹤0.01% 2829
2025
Q4 		$152K Buy
21,834
+7
+0% +$39 ﹤0.01% 2562
2025
Q3 		$101K Buy
+21,827
New +$102K ﹤0.01% 2508

Other funds holding TLSI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return
White Pine Capital
White Pine Capital Bloomington, Minnesota $419M AUM 48.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

CAPTRUST Financial Advisors's TLSI Position: Q3 2026 in Review

CAPTRUST Financial Advisors sold out of TriSalus Life Sciences (TLSI) in Q3 2026, closing a stake of 24,159 shares — an estimated $110K sold.

CAPTRUST Financial Advisors first reported a position in TLSI in Q3 2025 and held it in 4 quarters. The position peaked at $152K in Q4 2025. 45 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

  • CAPTRUST Financial Advisors reported no remaining TriSalus Life Sciences position as of Q3 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 24,159 TriSalus Life Sciences shares in Q3 2026, an estimated $110K.
  • CAPTRUST Financial Advisors first reported a position in TriSalus Life Sciences in Q3 2025 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's TriSalus Life Sciences position peaked at $152K in Q4 2025.
  • 45 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.